🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess treatment satisfaction on Day 57 in p...
Status
Completed
Location
Almirall Investigational Site 1
Start Date
2023-01-20
Trial ID
NCT05741294
Treatments Being Tested
The standard of care for patients with bone-metastatic, castrate-resistant ...
Status
Completed
Location
University of Chicago
Start Date
2010-02
Trial ID
NCT01074138
Treatments Being Tested
The purpose of the study is to evaluate patient reported outcomes (PROs) in...
Status
Completed
Location
Almirall Investigational Site 1
Start Date
2022-03-09
Trial ID
NCT05260073
Treatments Being Tested
This is a Phase I dose escalation study to assess the safety, tolerability ...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-27
Trial ID
NCT05522816
The purpose of the study is to evaluate the efficacy and safety of tirbanib...
Status
Completed
Location
Site 17
Start Date
2023-12-21
Trial ID
NCT06135415
Treatments Being Tested
The aim of the study is to evaluate the efficacy and safety of a combined a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11-30
Trial ID
NCT07273656
Treatments Being Tested
This Phase 1b study will determine the maximum tolerated dose of KX2-391 gi...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2013-12
Trial ID
NCT01397799
Treatments Being Tested
The purpose of the study is to evaluate the safety, tolerability and treatm...
Status
Completed
Location
Almirall Investigation Site 7
Start Date
2022-06-28
Trial ID
NCT05279131
Treatments Being Tested
Interventional, monocentric, national, single-arm, uncontrolled, open, pros...
Status
Completed
Location
Medizinische Universität Graz
Start Date
2023-05-11
Trial ID
NCT05900258
Treatments Being Tested
RATIONALE: KX2-391 may stop the growth of cancer cells by blocking some of ...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2007-10
Trial ID
NCT00646139
Treatments Being Tested